Significance of Perivascular Lymphocytic Infiltrates on Survival of Patients With Invasive Cervical Cancer

Journal of Immunotherapy

Volumn 26, Issue 2, 2003, Pages 149-155

  Yamazawa, Koji ^a   Matsui, Hideo ^a   Ishikura, Hiroshi ^a   Seki, Katsuyoshi ^a   Mitsuhashi, Akira ^a   Sekiya, Souei ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Cervical cancer; Perivascular lymphocytic infiltrates; Survival; Vascular invasion

Indexed keywords

ADULT; AGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HAZARD ASSESSMENT; HISTOPATHOLOGY; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVARY METASTASIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; TUMOR VOLUME; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; BIOPSY, NEEDLE; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; JAPAN; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 0037336077     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/00002371-200303000-00007     Document Type: Article

References (26)

1. Delgado G, Bundy BN, Fowler Jr, WC et al. A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a GOG study. Gynecol Oncol 1989; 35:314-320.
2. Zaino RJ, Ward S, Delgado G, et al. Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix: a GOG study. Cancer 1992; 69:1750-1758.
3. Roman LD, Felix JC, Muderspach LI, et al. Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix. Gynecol Oncol 1998; 68:220-225.
4. Sakuragi N, Takeda N, Hareyama H, et al. A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma. Cancer 2000; 88:2578-2583.
5. van Nagell Jr, JR Donaldson ES, Wood EG, Parker Jr. JC The significance of vascular invasion and lymphocytic infiltration in invasive cervical cancer. Cancer 1978; 41:228-234.
6. Chao HT, Wang PH, Tseng JY, et al. Lymphocyte-infiltrated FIGO stage IIB squamous cell carcinoma of the cervix is a prominent factor for disease-free survival. Eur J Gynaec Oncol 1999; 20:136-140.
7. Bethwaite PB, Holloway LJ, Thornton A, Delahunt B. Infiltration by immunocomponent cells in early stage invasive carcinoma of the uterine cervix: a prognostic study. Pathology 1996; 28:321-327.
8. Kradin RL, Bhan AK. Tumor infiltrating lymphocytes. Lab Invest 1993; 69:635-638.
9. Ambros RA, Kurman RJ. Identification of patients with stage I uterine endometrioid adenocarcinoma at high risk of recurrence by DNA ploidy, myometrial invasion, and vascular invasion. Gynecol Oncol 1992; 45:235-239.
10. Ambros RA, Kurman RJ. Combined assessment of vascular invasion and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus. Cancer 1992; 69:1424-1431.
11. Yamazawa K, Seki K, Matsui H, Sekiya S. Significance of perivascular lymphocytic infiltrates in endometrial carcinoma. Cancer 2001; 91:1777-1784.
12. Scully RE, Bonfiglio TA, Kurman RJ, et al. Histological typing of female genital tract tumors. 2nd ed. New York, NY: Springer-Verlag; 1994:39-54.
13. Creasman WT. New gynecologic cancer staging. Gynecol Oncol 1995; 58:157-158.
14. Shepherd JH. Cervical and vulva cancer: changes in FIGO definitions of staging. Br J Obstet Gynaecol 1996; 103:405-406.
15. Wright TC, Ferenczy A, Kurman RJ. Carcinoma and other tumors of the cervix. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract. 4th ed. New York, NY: Springer-Verlag; 1994:279-326.
16. Tsuruchi N, Kaku T, Kamura T, et al. The prognostic significance of lymphovascular space invasion in endometrial cancer when conventional hemotoxylin and eosin staining is compared to immunohistochemical staining. Gynecol Oncol 1995; 57:307-312.
17. Landoni F, Maneo A, Colombo A, et al. Randomized study of radical surgery versus radiotherapy for stage Ib - IIa cervical cancer. Lancet 1997; 350:535-540.
18. Schorge JO, Lee KR, Lee SJ, et al. Early cervical adenocarcinoma: selection criteria for radical surgery. Obstet Gynecol 1999; 94:386-390.
19. Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States-a 24-year population-based study. Gynecol Oncol 2000; 78:97-105.
20. Kleter B, Doorn LJ, Schegget JT, et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998; 153:1731-1739.
21. Hilders CGJM, Houbiers JGA, van Ravenswaay Claasen HH, et al. Association between HLA-expression of immune cells in cervical carcinoma. Lab Invest 1993; 69:651-659.
22. Zinkernagel RM, Doherty PC. MHC-restricted cytotoxic T-cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv Immunol 1979; 27:51-177.
23. Hohn H, Pilch H, Gunzel S, et al. CD4+ tumor infiltrating lymphocytes in cervical cancer recognize HLA-DR-restricted peptides provided by human papillomavirus-E7. J Immunol 1999; 163:5715-5722.
24. Hohn H, Pilch H, Gunzel S, et al. Human papillomavirus type 33 E7 peptides presented by HLA-DR 0402 to tumor-infiltrating T cells in cervical cancer. J Virol 2000; 74:6632-6636.
25. Kono K, Ressing ME, Brandt RMP, et al. Decreased expression of signal-transducing chain in peripheral T cells and natural killer cells in patients with cervical cancer. Clin Cancer Res 1996; 2:1825-1828.
26. Moy PM, Holmes EC, Golub SH. Depression of natural killer cytotoxic activity in lymphocytes infiltrating human pulmonary tumors. Cancer Res 1985; 45:57-60.